Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$1.2M
Filings
11
Firms Hired
1
Active Period
2024–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Patients Deserve Price Tags Act
2026 · third_quarter · Firm: CLARITEV (FORMERLY MULTIPLAN CORPORATION)
Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355/HR 5582: Patients Deserve Price Tags Act including issues related to price and coverage transparency
Client expense: $100,000 · Firm income: —
Matched citations: HR 5582
Patients Deserve Price Tags Act
2026 · third_quarter · Firm: CLARITEV (FORMERLY MULTIPLAN CORPORATION)
Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355/HR 5582: Patients Deserve Price Tags Act including issues related to price and coverage transparency
Client expense: $100,000 · Firm income: —
Matched citations: S.2355
Patients Deserve Price Tags Act
2026 · second_quarter · Firm: CLARITEV (FORMERLY MULTIPLAN CORPORATION)
Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355/HR 5582: Patients Deserve Price Tags Act including issues related to price and coverage transparency
Client expense: $130,000 · Firm income: —
Matched citations: HR 5582
Patients Deserve Price Tags Act
2026 · second_quarter · Firm: CLARITEV (FORMERLY MULTIPLAN CORPORATION)
Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355/HR 5582: Patients Deserve Price Tags Act including issues related to price and coverage transparency
Client expense: $130,000 · Firm income: —
Matched citations: S.2355
Patients Deserve Price Tags Act
2026 · first_quarter · Firm: CLARITEV (FORMERLY MULTIPLAN CORPORATION)
Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355/HR 5582: Patients Deserve Price Tags Act including issues related to price and coverage transparency
Client expense: $160,000 · Firm income: —
Matched citations: HR 5582
Patients Deserve Price Tags Act
2026 · first_quarter · Firm: CLARITEV (FORMERLY MULTIPLAN CORPORATION)
Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355/HR 5582: Patients Deserve Price Tags Act including issues related to price and coverage transparency
Client expense: $160,000 · Firm income: —
Matched citations: S.2355
Patients Deserve Price Tags Act
2025 · fourth_quarter · Firm: CLARITEV (FORMERLY MULTIPLAN CORPORATION)
Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355: Patients Deserve Price Tags Act including issues related to price and coverage transparency
Client expense: $150,000 · Firm income: —
Matched citations: S.2355
Patients Deserve Price Tags Act
2025 · third_quarter · Firm: CLARITEV (FORMERLY MULTIPLAN CORPORATION)
Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355: Patients Deserve Price Tags Act including issues related to price and coverage transparency
Client expense: $160,000 · Firm income: —
Matched citations: S.2355
Source: Senate LDA